azure b has been researched along with myricetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, Y; Fuse, S; Matsumura, K; Sugimoto, H; Takahashi, T | 1 |
| Goedert, M; Hasegawa, M; Hisanaga, S; Iwatsubo, T; Masuda, M; Suzuki, N; Taniguchi, S | 1 |
2 other study(ies) available for azure b and myricetin
| Article | Year |
|---|---|
Development of dual targeting inhibitors against aggregations of amyloid-β and tau protein.
Topics: Amyloid beta-Peptides; Drug Evaluation, Preclinical; Heterocyclic Compounds; Humans; Inhibitory Concentration 50; Peptide Fragments; Protein Multimerization; Protein Structure, Secondary; tau Proteins | 2014 |
Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins.
Topics: Antioxidants; Azure Stains; Benzophenones; Brain; Catechin; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Flavonoids; Fluorescent Dyes; Heparin; Humans; Methylene Blue; Microtubules; Models, Chemical; Neurofibrillary Tangles; Phenols; Phenothiazines; Polyphenols; Porphyrins; Protein Binding; Quinacrine Mustard; tau Proteins; Time Factors | 2005 |